ArticleCancer reports (Hoboken, N.J.)2024

Targeting androgen receptor (AR) with a synthetic peptide increases apoptosis in triple negative breast cancer and AR-expressing prostate cancer cell lines.

Mazdak Jamshidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.